Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
Dresden, GermanySeptember 10-13, 2019
Posters, Oral Presentation, and Sponsored Session
14th Dresden Symposium on Autoantibodies
Scientific posters utilizing Inova Diagnostics productsTitle Presenting Author Location
Anti-PAD4 antibodies can help close the seronegative gap in Rheumatoid Arthritis
Laura Martinez-Prat Poster B7
Clinical associations of anti-U11/U12 (RNPC-3) autoantibodies in patients with Systemic Sclerosis
Michael Mahler Poster A21
Clinical comparison of Aptiva™ with QUANTA Flash® for the detection of anti-dsDNA autoantibodies
Charles Warren Poster B23
Clinical evaluation of a particle-based mutli-analyte technology for the detection of anti-Th/To autoantibodies using Th/To subunits Rpp25 and Rpp38
Chelsea Bentow Poster A2
Clinical performance of a novel multi-analyte assay for the diagnosis of APS in a Spanish cohort
Andrea Seaman Poster A28
Comparison of immunodominant epitope recombinant RNPC-3 and RNPC-3 peptide as target of autoantibodies in patients with Systemic Sclerosis
Michael Mahler Poster A22
Evaluation of a novel chemiluminescent immunoassay for the detection of anti-intrinsic factor autoantibodies
Roger Albesa Poster C1
Evaluation of a novel bead based assay for the detection of HMGCR autoantibodies in idiopathic inflammatory myopathies
Charles Warren Poster B24
Evaluation of two distinct assays for the detection of anti-Th/To antibodies in Systemic Sclerosis: A cross-sectional study
Janire Perurena Prieto
Poster A3
Multi-center study for the association of anti-p80/coilin with anti-DFS70 in ANA positive patients
Fabrece Roup Poster B13
Pre-analytical evaluation of circulating calprotectin in serum and citrate plasma from healthy donors
Emily Fitzgerald Poster C23
Prevalence of anti-Ku antibodies in various Connective Tissue Diseases measured by a novel particle based multi-analyte technology
Charles Warren Poster B22
Reactivity profile of novel human monoclonal antibodies to SAE, TIF1γ, MDA5 and NXP2
Andrea Seaman Poster A29
Oral PresentationTitle Presenting Author Location/Time
Multi-center study for the association of anti-p80/coilin with anti-DFS70 in ANA positive patients
Fabrece RoupLecture Hall Friday Sept 13th 12:10-12:20
Sponsored SessionClosing the Gap in Autoimmunity: A Modern Approach
8:30 Understanding and addressing the gaps in autoantibody testing: Requirements for precision health Prof. Marvin Fritzler, University of Calgary, Canada
8:55 Anti-PAD antibodies in the serology of rheumatoid arthritis Laura Martinez-Prat, Inova Diagnostics, USA
9:15 Autoantibodies in myositis measured using a novel particle based multi-analyte technology Dr. Michael Mahler, Inova Diagnostics, USA
9:35 Autoantibody profiling in Celiac Disease: The value beyond tTG IgA Prof. Xavier Bossuyt, University Hospitals Leuven, Belgium
9:55 Performance evaluation of the Aptiva Antiphospholipid Syndrome panelProf. Savino Sciascia, University of Torino, Italy
10:15 Glycosylation of antibodies in autoimmune diseases: Special focus on Fab glycans Prof. René Toes, Universiteit Leiden, The Netherlands
D AT E : Wednesday, September 11th
T I M E : 8:30 – 10:30
Stay in touch!
Subscribe to our mailing list and receive exclusive product and workshop information, including a digital copy of our posters and presentations.
Talk to one of our booth representatives or visit inovadx.com/Dresden2019 to learn more.
Aptiva™ is in development. Product not for sale.
www.inovadx.com
Inova Diagnostics, Inc. 9900 Old Grove Road San Diego • CA • 92131-1638Tel. 858-586-9900 • Toll free. 800-545-9495
690677 September 2019 Rev. 0
Together, let’s transform autoimmune diagnostics
Increase diagnostic confidence by offering clinicians the most comprehensive autoimmune test menu and improved clinical performance
Improve diagnostic accuracy by helping to close the seronegative gap with clinically significant, novel biomarkers
Increase efficiency of your lab by improving resource utilization and realizing the full potential of multi-analyte testing and advanced automation
Lead your lab to the forefront